Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Long-Term Debt Issuances (2018 - 2025)

Haemonetics has reported Long-Term Debt Issuances over the past 4 years, most recently at -$700.0 million for Q1 2025.

  • For Q1 2025, Long-Term Debt Issuances fell 736.36% year-over-year to -$700.0 million; the TTM value through Dec 2025 reached -$700.0 million, down 186.42%, while the annual FY2024 figure was $110.0 million, 60.71% down from the prior year.
  • Long-Term Debt Issuances for Q1 2025 was -$700.0 million at Haemonetics, down from $700.0 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $700.0 million in Q2 2024 and troughed at -$700.0 million in Q1 2025.
  • A 3-year average of $85.0 million and a median of $170.0 million in 2023 define the central range for Long-Term Debt Issuances.
  • Biggest five-year swings in Long-Term Debt Issuances: tumbled 52.17% in 2024 and later crashed 736.36% in 2025.
  • Year by year, Long-Term Debt Issuances stood at $230.0 million in 2023, then skyrocketed by 204.35% to $700.0 million in 2024, then crashed by 200.0% to -$700.0 million in 2025.
  • Business Quant data shows Long-Term Debt Issuances for HAE at -$700.0 million in Q1 2025, $700.0 million in Q2 2024, and $110.0 million in Q1 2024.